Retinal vein occlusion, homocysteine, and methylene tetrahydrofolate reductase genotype

Investigative Ophthalmology and Visual Science

Volumn 46, Issue 12, 2005, Pages 4712-4716

  McGimpsey, Stuart J ^a   Woodside, Jayne V ^b   Bamford, Louise ^a   Gilchrist, Sarah E C M ^b   Graydon, Ryan ^b   McKeeman, Gareth C ^b   Young, Ian S ^b   Hughes, Anne E ^a   Patterson, Chris C ^b   O'Reilly, Dermot ^b   McGibbon, David ^b   Chakravarthy, Usha ^b  

^a ROYAL GROUP OF HOSPITALS   (United Kingdom)

^b QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2);

ADULT; AGE; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; FOLIC ACID BLOOD LEVEL; GENDER; GENE FREQUENCY; GENOTYPE; HOMOZYGOTE; HUMAN; HYPERHOMOCYSTEINEMIA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETINA VEIN OCCLUSION; RISK FACTOR; VITAMIN BLOOD LEVEL; BLOOD; CASE CONTROL STUDY; GENETIC POLYMORPHISM; GENETICS; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION;

AGED; CASE-CONTROL STUDIES; DNA MUTATIONAL ANALYSIS; FEMALE; FOLIC ACID; GENOTYPE; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; RETINAL VEIN OCCLUSION; RISK FACTORS; VITAMIN B 12;

EID: 33644807348     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.04-1229     Document Type: Article

References (27)

1. Boushey CJ, Beresford SA, Omenn GS, Motulsky AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. JAMA. 1995;274:1049-1057.
2. Cahill M, Karabatzaki M, Meleady R, et al. Raised plasma homocysteine as a risk factor for retinal vascular occlusive disease. Br J Ophthalmol. 2000;84:154-157.
3. Martin SC, Rauz S, Marr JE, Martin N, Jones AF, Dodson PM. Plasma total homocysteine and retinal vascular disease. Eye. 2000;14:590-593.
4. Vine AK. Hyperhomocysteinemia: a risk factor for central retinal vein occlusion. Am J Ophthalmol. 2000;129:640-644.
5. Marcucci R, Bertini L, Giusti B, et al. Thrombophilic risk factors in patients with central retinal vein occlusion. Thromb Haemostasis. 2001;86:772-776.
6. Larsson J, Hultberg B, Hillarp A. Hyperhomocysteinemia and the MTHFR C677T mutation in central retinal vein occlusion. Acta Ophthalmol Scand. 2000;78:340-343.
7. Pianka P, Almog Y, Man O, Goldstein M, Sela B-A, Loewenstein A. Hyperhomocysteinemia in patients with nonarteritic anterior ischemic optic neuropathy, central retinal artery occlusion, and central retinal vein occlusion. Ophthalmology. 2000;107:1588-1592.
8. Boyd S, Owens D, Gin T, et al. Plasma homocysteine, methylenetetrahydrofolate reductase C677T and factor II G20210A polymorphisms, factor VIII, and VWF in central retinal vein occlusion. Br J Ophthalmol. 2001;85:1313-1315.
9. Young IS, Woodside JV. Folate and homocysteine. Curr Opin Clin Nutr Metab Care. 2000;3:427-432.
10. Graham IM, Daly LE, Refsum HM, et al. Plasma homocysteine as a risk factor for vascular disease: the European Concerted Action Project. JAMA. 1997;277:1775-1781.
11. Harmon DL, Woodside JV, Yarnell JW, et al. The common 'thermolabile' variant of methylene tetrahydrofolate reductase is a major determinant of mild hyperhomocysteinaemia. QJM. 1996;89:571-577.
12. Ubbink JB, Vermaak WJH, Bissbort S. Rapid high-performance liquid Chromatographic assay for total homocysteine levels in human serum. J Chromatogr. 1991;565:44l-446.
13. Frosst P, Blom HJ, Milos R, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nature Genet. 1995;10:111-113.
14. Brown BA, Marx JL, Ward TP, et al. Homocysteine: a risk factor for retinal venous occlusive disease. Ophthalmology. 2002;109:287-290.
15. Weger M, Stanger O, Deutschmann H, et al. Hyperhomocyst(e)inemia and MTHFR C677T genotypes in patients with central retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol. 2002;240:286-290.
16. Weger M, Stanger O, Deutschmann H, et al. Hyperhomocyst(e)inemia but not methylenetetrahydrofolate reductase C677T mutation, as a risk factor in branch retinal vein occlusion. Ophthalmology. 2002;109:1105-1109.
17. Loewenstein A, Goldstein M, Winder A, Lazar M, Eldor A. Retinal vein occlusion associated with methylenetetrahydrofolate reductase mutation. Ophthalmology. 1999;106:1817-1820.
18. Marucci R, Giusti B, Evangelista L, et al. Genetic determinants of fasting and post methionine hyperhomocysteinemia in patients with retinal vein occlusion. Thromb Res 2003;110:7-12.
19. Cahill M, Karabatzaki M, Donoghue C, et al. Thermolabile MTHFR genotype and retinal vascular occlusive disease. Br J Ophthalmol. 2001;85:88-90.
20. Glueck CJ, Bell H, Vadlamani L, et al. Heritable thrombophilia and hypofibrinolysis: possible causes of retinal vein occlusion. Arch Ophthalmol. 1999;117:43-49.
21. Salomon O, Moisseiev J, Rosenberg N, et al. Analysis of genetic polymorphisms related to thrombosis and other risk factors in patients with retinal vein occlusion. Blood Coag Fibrinol. 1998;9:617-622.
22. Nygard O, Refsum H, Ueland PM, Vollset SE. Major lifestyle determinants of plasma total homocysteine distribution: the Hordaland Homocysteine Study. Am J Clin Nutr. 1998;67:263-270.
23. Nygard O, Nordrehaug JE, Refsum H, et al. Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med. 1997;337:230-236.
24. Omland T, Samuelsson A, Hartford M, et al. Serum homocysteine concentration as an indicator of survival in patients with acute coronary syndromes. Arch Intern Med. 2000;160:1834-1840.
25. Morita H, Kurihara H, Kuwaki T, et al. Homocysteine as a risk factor for restenosis after coronary angioplasty. Thromb Haemost. 2000;84:27-31.
26. Hayreh SS, Zimmerman B, McCarthy MJ, Podhajsky P. Systemic diseases associated with various types of retinal vein occlusion. Am J Ophthalmol. 2001;131:61-77.
27. Tsaloumas MD, Kirwan J, Vinall H, et al. Nine year follow-up study of morbidity and mortality in retinal vein occlusion. Eye. 2000;14:821-827.